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ABSTRACT This article addresses how quantitative models such as the one proposed in the companion article can be used to
study cellular network perturbations such as knockdowns and pharmacological perturbations in a predictive manner. Using the
kinetic model for cytosolic calcium dynamics in RAW 264.7 cells developed in the companion article, the calcium response
to complement 5a (C5a) for the knockdown of seven proteins (C5a receptor; G-b-2; G-a,i-2,3; regulator of G-protein signaling-10;
G-protein coupled receptor kinase-2; phospholipaseCb-3; arrestin) is predictedandvalidatedagainst thedata from theAlliance for
Cellular Signaling. The knockdown responses provide insights into howaltered expressions of important proteins in disease states
result in intermediate measurable phenotypes. Long-term response and long-term dose response have also been predicted,
providing insights into how the receptor desensitization, internalization, and recycle result in tolerance. Sensitivity analysis of long-
term response shows that the mechanisms and parameters in the receptor recycle path are important for long-term calcium
dynamics.
INTRODUCTION
In the companion article (part 1), a kinetic model for calcium
signaling in macrophage-like RAW 264.7 cells was devel-
oped for stimulation with the ligand complement 5a (C5a).
Upon stimulation with C5a, cytosolic Ca21 concentration
([Ca21]i) increases, and this is attributed to ligand-induced
release of calcium from the endoplasmic reticulum (ER)
caused by increased activation and opening of the inositol
1,4,5-trisphosphate (IP3) receptor (IP3R) channels on the ER
membrane. Activity of IP3R channels is increased due to
binding of IP3 and Ca
21. IP3 is generated through hydrolysis
of phosphatidylinositol 4,5-bisphosphate (PIP2) into IP3 and
diacylglycerol (DAG) (1,2). Increased mobilization of cal-
cium upon calcium binding to IP3R is also referred to as
calcium-induced calcium release (CICR) (3–5). Increased
hydrolysis of PIP2 is due to activated phospholipase C-b
(PLCb). The activation of the C5a receptor (C5aR) and the
GTPase cycle of the G-protein Gi have been modeled in
sufﬁcient detail, including the desensitization, internaliza-
tion, and recycling of the receptor (Fig. 1). The three-site
model of IP3 and Ca
21 binding to IP3 receptor proposed by
De Young and Keizer (6) and later simpliﬁed by Li and
Rinzel (7) has been used to model calcium ﬂux from the ER
to the cytosol. The calcium released binds to various proteins
such as calmodulin (CaM) to regulate downstream functions.
Calcium is also pumped back to the ER by the sarco(endo)-
plasmic reticulum calcium ATPase (SERCA) pump. Some
calcium is expelled to the extracellular space through the
Na1/Ca21 exchanger (NCX) and the plasma membrane cal-
cium ATPase (PMCA) pump. Calcium exchange with the
mitochondria also has been observed at elevated levels of
[Ca21]i (8). Our model, despite being coarse grained and
simple whenever possible, included the details of several
mechanisms so that the knockdown (KD) of important pro-
teins such as G-protein coupled receptor (GPCR) kinase
(GRK) and GTPase-activating proteins (GAP) can be studied
quantitatively (Fig. 1).
A quantitative model can be used to study the effect of
structural/biochemical and parametric perturbations. Bio-
chemical alterations such as under/overexpression of proteins
have been implicated in many diseases. Examples relevant to
the present model include decreased Ga,i levels in Alz-
heimer’s disease (9) and increased blood pressure in regulator
of G-protein signalling (RGS)2/ mice (10,11). This article
addresses how quantitative models such as the one proposed
in the companion article can be used to predict the effect of
cellular network perturbations such as KDs and pharmaco-
logical interventions, which can be validated experimentally.
Part 1 of this two-part article focused on the development
of a kinetic model using the in vivo data exhibiting sub-
population variability from the Alliance for Cellular Signal-
ing (AfCS) measurements (12). As discussed in part 1, most
existing models have not explored the importance of the re-
ceptor desensitization, internalization, and recycling in long-
term response. In this article we show that accurate modeling
of the recovery processes is crucial for the understanding of
the long-term behavior of calcium response and the down-
stream affected processes (13). The effect of KDs has also
rarely been studied in a quantitative and kinetic context. This
part (part 2) deals with the prediction and analyses of KD
response and long-term response using the model developed
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in part 1. Fig. 1 (same as Fig. 1 in part 1) has been reproduced
here for the purpose of clarity of the analyses presented. First
the results of KD are presented as they have been validated
qualitatively against the AfCS data. Sensitivity analysis of
KD responses is also carried out. Then, the results on pre-
dicted long-term response, which serve as testable hypoth-
eses, are presented. The KD response has revealed a
multiplicity of features in calcium response. These include,
with increasing KD, sharp initial decrease, increased basal
level, increased rise time, and increased response. Further,
our analysis of the long-term response provides an interest-
ing ﬁnding, i.e., that the recycle path is important for calcium
dynamics. This was not transparent in the study of short-term
calcium response.
MATERIALS AND METHODS
To model the KD of a protein, using the values of the parameters (kinetic
parameters, initial conditions, and buffered species concentrations) for the
base case, the reduced value of the concerned parameter is computed as
xKD ¼ x3ð1%knockdown=100Þ where x is the base value of the affected
variable. Then any calculated parameters that could be dependent on the
value of the variable being altered due to KD are computed and the new
initial basal steady state is computed by allowing the system to evolve for
;1000 s and then solving the algebraic equations. The new basal state is
computed whenever it is different from the initial basal state, e.g., when one
or more parameters are changed. Besides this change, the simulations are
carried out as described in Materials and Methods in the companion article.
KD response is predicted using the parameters for the master data set and
with a 30 nM C5a stimulation for all KDs. Dynamic response upon ligand
application under KD of seven different proteins, one at a time, has been
simulated. In the AfCS experiments (14), these proteins are 1) the receptor
C5aR (R), 2) Gb-2, 3) Gai-2,3 (a double KD), 4) the Gai GAP, RGS10,
5) GPCR kinase, GRK2, 6) PLCb-3, and 7) arrestin. In the model, these KDs
are represented by reductions in the initial conditions of 1) C5aR (R), 2) Gbg,
and 3) GaiD; 4) the buffered level of the GAP, A; 5) GRKtot; 6) PLCbtot; and
7) the buffered level of arrestin. For the double KDs of Gai-2 and Gai-3,
since both are isoforms of Gai and we include only one isoform in our model
for the sake of simplicity, this double KD is modeled by the (single) KD of
IC:GaiD.
RESULTS
Prediction of knockdown response
Fig. 2 A–F, shows the temporal response of [Ca21]i and the
KD response curve (peak height versus KD level) for the KD
of six proteins. The KD levels simulated are 1%, 5%, 25%,
50%, 60%, 75%, 80%, 85%, and 90%. In Fig. 2, the response
without KD (0% KD) is also included. The main results are
presented below. For the KD of the seventh protein, arrestin,
there is no noticeable change in [Ca21]i response in the short
term (0–300 s). Hence, it is not shown in Fig. 2. By com-
parison with the in vivo data from AfCS (14), we have veri-
ﬁed that the predicted KD response is qualitatively correct in
terms of increase or decrease in the peak height for all KDs
except for Gai, for which conﬂicting phenotypes have been
observed in the AfCS experiments.
Knockdown of the receptor C5aR (R)
As shown in Fig. 2 A, with increasing levels of KD, peak
height decreases (both panels) and the time to reach the
peak increases (left panel). With decreasing R, in general,
FIGURE 1 A simpliﬁed model for
calcium dynamics. (A) Overall sche-
matic model. The ligand C5a binds to its
receptor C5aR on the plasmamembrane
(PM) activating G-protein Gi. The free
subunit Gbg binds to and activates
PLCb, which hydrolyses PIP2 into IP3
andDAG. IP3 binds to its receptor on the
ER membrane, and the IP3R channels
open to release calcium into the cytosol
(Jch ¼ calcium ﬂux through the IP3R
channel, JPM;IP3dep¼ IP3-dependent ﬂux
into the cytosol across the PM). Other
calcium ﬂuxes, e.g., with mitochondria
and extracellular space, are also shown.
(B) The mechanisms for the receptor
module (box 1), GTPase cycle module
(box 2), and IP3 generation module
(box 3), and the feedback effects (boxes
1 and 4). Abbreviations: IP3,p, a lumped
product of IP3 phosphorylation; Cai,
cytosolic Ca21; mit (subscript), mito-
chondria; L, ligand C5a; R, receptor
C5aR; Arr, arrestin; Pi, phosphate.
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MAX([L.R]) also decreases. Thus, the activation level of the
GTPase cycle decreases and lesser free Gbg is available. This
leads to lesser activation of PLCb and reduced hydrolysis of
PIP2 into IP3, which results in a lowered ﬂux of [Ca
21] from
the ER to the cytosol and hence a lower peak is observed.
The dynamic response for 50% KD is labeled with arrows in
both the panels. The KD level required to reduce the peak
height by 50% with respect to a scale normalized by the
range of the y axis, i.e., 0% for the lowest peak (at 90% KD
of C5aR) and 100% for the highest peak (no KD), is 59.2%.
Since C5a and C5aR bind in 1:1 stoichiometry, with de-
creasing Rtot, there is little change in response up to 5% KD.
Without KD, Rtot 0.04mM. So, at 5%KD, Rtot¼ 0.038mM,
which is still30 nM (ligand strength). Thus, the dynamics
of [L.R] remains almost the same. At 25% KD, some
reduction in response is observed. At 50% KD, the response
is reduced to the 65% level (peak height ;0.028 mM). As
Rtot is decreased the maximum peak height decreases and
the half-maximal effect concentration (EC50) for the dose
response curve also decreases (not shown). It may be noted
that the basal level does not change since, in our model, the
receptor comes into play only upon stimulation by the li-
gand. In reality, due to the little basal activity of the receptor
the basal level will decrease slightly, but it may be un-
detectable or may get nulliﬁed by the basal hydrolysis rate
of PIP2.
Knockdown of Gbg
Decrease in total Gbg leads to reduced level of free Gbg (Fig.
2 B). This directly affects the rate of PIP2 hydrolysis. Thus,
the response decreases with increasing KD in a manner
similar to the KD of C5aR. However, the decrease in re-
sponse is higher at lower percentage KDs and plateaus at
high KD. At very high KD, the differential decrease in
response is almost zero. This can be explained by noting that
FIGURE 2 KD response predicted using the parameters for the master data set and 30 nMC5a for all KDs. For six KDs, the temporal response of [Ca21]i and
the KD response curve (peak height versus KD level) are shown. (A) KD of C5aR. With an increasing level of KD, peak height decreases (both panels) and the
time to reach peak increases (left panel). KD level required to reduce the peak height by 50% of the range of y axis is 59.2%. (B) KD of Gbg. The response
decreases with increasing KD similar to the KD of C5aR. However, initially, it decreases sharply compared to that at higher KD levels. Only 18% KD is
required to reduce the peak height by 50% and at 50% KD, the peak height is reduced to 6%–8% level. (C) KD of Gai. With increasing KD, peak height
increases in a proportional manner. Basal level also increases with increasing KD. (D) KD of the GAP RGS10. Most features of the temporal response and peak
height are similar to that the KD of Gai except that the basal response remains nearly unchanged. (E) KD of GRK. Although peak height increases with
increasing KD more strongly compared to other KDs, the time to return to a speciﬁc percentage level, e.g., compared to the peak level for the chosen temporal
curve, also increases (see text for explanation). (F) KD of PLCb. The KD response is qualitatively similar to that of the KD of Gbg. However, the response
decreases less drastically. The KD level for 50% reduction in response is 30% compared to just 18% for the KD of Gbg.
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at very high KD, there is little free Gbg and the scenario is
almost like the basal response. The initial sharp decrease is
due to the fact that with increasing KD of the total Gbg, the
level of free Gbg decreases drastically. This is because the
Gbg,tot and Gai,tot are present in ;1:1 ratio in the absence of
KD and that the a and bg subunits bind in a 1:1 ratio. Thus,
when Gbg,tot drops below Gai,tot, GaiD binds to almost all of
it (see also the KD of Gai). GRK also competes for binding to
Gbg. Initially, with increasing KD, decrease in response is so
drastic that only 18% KD is required to reduce the peak
height by 50% and at 50% KD, the peak height is reduced to
a 6%–8% level compared to the native cells. The basal level
decreases slightly by the KD, but since basal activity of the
GTPase cycle is already quite low and the intrinsic hydro-
lytic activity of PIP2 is not affected, this decrease may not
be detectable.
Knockdown of Gai (GaiD)
Analogous to the explanation above, with increasing KD of
Gai, more Gbg is free, nearly in a proportional manner since
Gbg,tot and Gai,tot are in an ;1:1 ratio in the native cells.
Hence the peak height also increases accordingly (Fig. 2 C).
One striking difference between the KD of Gai and the KD of
other proteins tested is that the basal level also increases with
increasing KD. This is because with increased KD of Gai, the
fraction of free Gbg in the basal state also increases. This
amounts to having some G-protein activity without a stimulus.
Interpreting the results of this KD can be difﬁcult and
anomalous. We have been able to quantitatively capture this
behavior by assuming that Ca21 is able to enter the cytosol
from the extracellular matrix (ECM) through leakage and an
IP3-dependent ﬂux which serves as a feed-forward signal
in regulating [Ca21]i (see the mathematical model in the
Materials and Methods section in part 1). It has been sug-
gested that the KD of Gai may result in a decreased response
since during stimulation chelator EDTA is used in the ex-
ternal medium. However, this is unlikely because after the
KD, the cells grow for several generations and hence calcium
must be present in the ECM during that phase. Necessary
calcium will enter the cytosol and maintain a sufﬁciently
high level of calcium in the ER in the basal state. It appears
that the chelator is added a short time before the ligand
addition. Although this results in the expulsion of some cal-
cium to the ECMwith Gai KD since basal levels are high, the
amount would not be large and hence [Ca21]ER at the time of
ligand addition would not be too low though it would be
lower compared to the value without KD of Gai. Notably, a
lowered level of [Ca21]ER has been associated with Alzheimer’s
disease (15). Thus, upon stimulation, an increased peak
should be observed, as is the case with the data set 3 used in
the companion article. However, if the chelator is added long
before the stimulation then [Ca21]ER can get very low.
Hence, a reduced response would be observed. It can be
noted that under such circumstances, the cells may expel all
the calcium and die because the PMCA and NCX pumps are
not blocked (16–18).
Knockdown of RGS10, a GAP (A) for Gai
Most features of the temporal response and peak height are
similar to the KD of Gai except that the basal response
remains nearly unchanged (Fig. 2 D). With increasing KD,
during stimulation lesser GaiT is hydrolyzed into GaiD, so
lesser GaiD is present to bind to Gbg and, hence, more Gbg
is in free active state. Further, the time to reach the peak
increases with increasing KD. This is because after ligand
addition, at any given time with the KD of RGS10 more free
Gbg is available compared to the native cells. Higher [Gbg]
results in increased activation of PLCb, leading to increased
production of [IP3]. The resulting increase in channel ﬂux,
Jch, leads to higher peak response. Also, KD of RGS10
means slower turning off of the GTPase cycle (19). Thus,
a larger channel ﬂux is observed for a longer time. The
cumulative effect is the increased peak response and larger
time required to attain that response.
Knockdown of GRK
The phenotype of GRK KD is different from others in two
aspects: 1) the peak height increases with increasingKDmore
strongly compared to other KDs (Fig. 2 E); and 2) the time to
return to a speciﬁc percentage level, e.g., compared to the
peak response of the chosen temporal curve, also increases.
For other KDs the fall time nearly remains unchanged (Fig.
2 E). This is because with lowered GRK the receptor and
hence theGTPase cycle is active for longer times. In fact, with
increasing KD, the ﬂux through the SERCA pump becomes
more and more responsible for the decrease phase. As op-
posed to this, for all other KD scenarios, the turning off of the
receptor and the GTPase cycle modules themselves are
equally responsible for attaining the peak and the subsequent
decrease in [Ca21]i. Due to delayed turning off of the receptor
activity, the time to reach the peak is also increased. This
feature is similar to the KD of RGS10 presented above. The
KD response is nearly linear here, in a manner similar to the
KD of Gai and RGS10. At very large KD of GRK, there is
little phosphorylation of the active receptor. Thus, the recep-
tor is active for more than 100–200 s. Due to this prolonged
activity, both the channel Jch and JSERCA saturate or, more
precisely, level off due to their M-M or Hill kinetics de-
pendence on [IP3] and/or [Ca
21]i. Hence, the difference of Jch
and JSERCA is also nearly constant. This results in a linear
decrease in response in the time domain (Fig. 2 E, left panel).
Knockdown of PLCb
With increasing KD levels of PLCb, the response of calcium
decreases (Fig. 2 F). The KD response is qualitatively similar
to that of the KD of Gbg. However, the response decreases
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less drastically. The KD level for 50% reduction in response
is 30% compared to merely 18% for the KD of Gbg. Sim-
ilarly, at 50% KD, response is reduced to the 25% level
compared to the 6%–8% level for 50% KD of Gbg. The
decrease in response was much sharper for the KD of Gbg
since Gbg acted as a limiting reactant.
It is interesting to note that each of the KDs presented
here has one or more special features, such as sharp initial
decrease (Fig. 2 B), increased basal level (Fig. 2C), increased
rise time (Fig. 2 D–E), and increased response (Fig. 2, C–E).
These features are summarized in Table 1. Further, all KDs
that result in increased response are linear, whereas the rest
exhibit nonlinear KD response curves. This is because the
main focal point of increase in response is the increase in the
release of calcium from ER. Due to the saturation effect, e.g.,
through the Michaelis-Menten parameter, KM, once sufﬁ-
ciently high levels are reached, further increase in the ﬂux is
small despite the third-power dependence of the calcium ﬂux
through the IP3R-channel, Jch, on h and otherM-M-like terms
(7). On the other hand, with decreasing response, we move
away from the saturation region into the more linear region of
M-M kinetics, resulting in a sharper decrease in peak height
due to the third-power dependence.
Since these results are based on the parameters for the
master data set only, when comparing to experimental data
from the KD cell lines, only qualitative comparison should
be made because due to subpopulation variability, excessive
differences in one or more of the capacity-like parameters
such as PLCbtot may counterbalance the expected behavior.
As an example, peak height for 50% KD in Fig. 2 F (based
on data set 1) is lower than that for 83% KD in Fig. 3 D
(panel 2) of part 1 that is based on data set 4. This can
be explained by subpopulation variability. In particular,
PLCbtot,set 4/PLCbtot,set 1 is 1.44 (optimized) in the absence
of KD. Hence, in data set 4, even with higher KD of PLCb,
a higher peak is observed.
Possible approach to quantitative validation of
knockdown response
As indicated above, quantitative experimental validation will
require controlling the subpopulation variability between the
control cell line and the KD cell line. This may be achieved
in two ways. The ﬁrst is to perform cell cycle synchroni-
zation in both control and KD cell lines before harvesting the
cells for ligand application. This can be achieved by arresting
the cells in a speciﬁc phase using appropriate pharmacolog-
ical inhibitors or through serum deprivation, which would
arguably not interact with the KD of interest; see Davis et al.
(20) and Chou and Langan (21) for a review. Cooper (22,23)
has discussed potential drawbacks of a serum deprivation
method. With cell cycle synchronization in place, the re-
sponse for a chosen dose of C5a in two different control
cell lines should be nearly the same, provided the number of
cells is large in both batches; any difference can only be
attributed to experimental errors. Then, we anticipate a good
quantitative match between the predicted and experimental
KD response. The second approach, which indirectly at-
tempts to emulate cell cycle synchronization without exper-
imentally enforcing it, is to prepare a very large batch of
growing cells and then divide them into thousands of sub-
populations. If one could locate two subpopulations with
nearly identical molecular properties such as basal calcium
levels, potentially they would be in synchronization. One
subpopulation can be harvested for control study and the
other for the KD study. We note that although the second
approach would avoid the unwanted effects of pharmaco-
logical inhibitors, it may be less practical due to the very
large batch size required and the difﬁculty in locating po-
tentially synchronized batches.
Sensitivity analysis of knockdown response
Fig. 3 shows the alterations in the KD response when the
parameter IC:[R] or Rtot is varied. The KD of R itself is not
shown here. Panels 1–6 show the response surface for the
KD of PLCb, arrestin, Gbg, GRK, GaiD, and RGS10,
respectively. The z axis is the peak height compared to the
basal level for the base case. The response surfaces shown in
panels 1 and 3 have three limiting regimes, only two in panel
2, and four limiting regimes in panels 4–6. In panel 1, the
limiting regimes correspond to: a), low KD of PLCb and low
IC:[R]; b), low KD and high IC:[R]; and c), high KD and any
value of IC:[R]. In panel 2, only two limiting regimes are
TABLE 1 The main features of the predicted KD responses of various proteins
Features of KD response with increasing KD level
Protein name Peak height Basal level Rise time Decay time constant
C5aR decreases, concave no change increases (2–4 s) increases (12 s)
Gb-2(Gbg) decreases sharply, convex small decrease (;1 nM) * *
Gai-2,3(Gai) increases, linear increases (10 nM) no change increases (;4 s)
RGS10 increases, linear no change increases (2–4 s) increases (;4 s)
GRK2 increases, linear no change increases (4–6 s) increases (2 min)
PLCb-3 decreases, convex small decrease (;1 nM) decreases (3–5 s) increases (7 s)
The rise time and decay time constant are assessed by normalizing and synchronizing the peaks for all KD levels. Rise time is taken as the time to reach the
peak. The decay time constant is the time required for the normalized response (basal level ¼ 0, peak ¼ 1) to decrease from the peak level to 0.37 (¼ e1).
*It is difﬁcult to assess the rise time and decay time constant since peak height is almost zero for 60% or higher KD levels.
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observed since the KD of arrestin has no impact on the short-
term response. The features of the response surface in panel 3
are similar to that in panel 1 because the rate of hydrolysis of
PIP2 is affected by both PLCbtot and Gbg in a similar manner
(reaction 18). The response surfaces in panels 4–6 are more
interesting, resulting in four limiting regimes since the KD




Although receptor recovery has been studied in the context
of G-protein signaling (24–26), it has been almost ignored in
the context of calcium signaling except for the recent study
by Lemon et al. (1). Hence, an in-depth analysis of receptor
recovery is carried out here. As stated in Table S4 of part 1,
the rate constant for receptor recycling (reaction 9), kf,9, is set
to 0.001/s. This value may be somewhat higher than reported
in the literature (24), but it has little impact on the short-term
response. The increased value is used to recover most of the
receptors in ;1 h. Sample simulations with other values of
kf,9 have shown that qualitative features of the model do not
change.
Long-term response and application of a second dose of C5a
of equal strength
Fig. 4 A shows the fraction of free surface receptors over a
period of 0–5000 s (;84 min) when 30 nM C5a is applied at
tLA (time of ligand addition) ¼ 0 s. It takes ;30 min to
recover 80% of the receptors and more than 90% of the
receptor is recovered in 60 min. Since kf,9 is the smallest of
all the rate constants in the recycle path (kf,6, kf,7*[Arr], and
kf,8), it is the rate-limiting step. Once the fraction of surface
receptors ([R]/Rtot) reaches its minimum of ;25%, the
remaining response appears like a ﬁrst-order process with a
time constant of ;1250 s.
If a second dose is applied soon after the ﬁrst dose, then
due to fast desensitization of the receptors, a lower second
FIGURE 3 KD response of various
proteins for variation in the parameter
IC:[R], the total surface receptor. In each
panel, the x axis is the percentage KD of
the chosen protein, and the y axis, on
log2 scale, is the perturbation ratio for
IC:[R] compared to its base value. The
z axis is the peak height. Panels 1–6 are
for the sensitivity of the KD response of
PLCb, arrestin, Gbg, GRK, GaiD, and
RGS10, respectively.
FIGURE 4 Prediction of long-term
response using the parameters for data
set 1 and 30 nM C5a dose. Recovery of
the receptor in the log term and the
effect of a second dose of 30 nM C5a is
shown. (A) Dynamic response of the
free surface receptors, represented as a
percentage of total surface receptors.
(B) Response with a second dose of 30
nM C5a. The ﬁrst dose is applied at 0 s
in each case. The second dose is applied
at different times. [Ca21]i response is
shown as change from the basal level as a percentage of the height of the ﬁrst peak after tLA¼ 0 s. With increasing tLA for the second dose, height of the second
peak increases since more receptors have been recovered when the second dose is applied. (C) Fraction of surface receptors corresponding to (B). The top curve
(thin dashed) depicts the response if only one dose were to be applied. The other curves, which appear to separate from the top curve after the time of applying
the second dose, depict the response after that time.
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peak is obtained whereas if applied a sufﬁciently long time
after the ﬁrst dose, much of the response is recovered due
to the internalization and the subsequent recycling of the
receptor. Fig. 4, B and C, shows the response of [Ca21]i and
[R] when one dose of 30 nM C5a is applied at 0 s (denoted
tLA,1); and in the same set of simulation, a second dose of 30
nM C5a is applied at different times (tLA,2 ¼ 100, 250, 500,
1000, and 2000 s). Fig. 4 B shows normalized [Ca21]i
response. In Fig. 4 C, the top curve (thin dashed) depicts the
response if only one dose were to be applied. The other
curves, which appear to separate from the top curve after
t ¼ tLA,2, depict the response after tLA,2. In general, with
increasing tLA,2, the height of the second peak of [Ca
21]i
increases since more receptors have been recovered when the
second dose is applied. The second peak is a little higher for
tLA,2¼ 100 s compared to for tLA,2¼ 250 s since [Ca21]i has
not yet returned to basal level at 100 s, thus bringing in the
effect of CICR. At later times, more and more receptor is
recovered through reactions 6–9. Hence, a nearly complete
response (;90%) is obtained for tLA,2 ¼ 2000 s.
Another interesting observation in Fig. 4 B is that for the
response due to the second dose at tLA,2¼ 100, 200, 500, and
1000 s, a third peak of very low height is obtained. This is
because for these cases, even after the second major peak,
some ligand is left unused which binds to free surface re-
ceptors, if available. The third peak is only a minor peak
because [R] drops to zero or is very small around the second
peak. It is interesting that even with very small amounts of R,
as long as some unused ligand is present, a response several
times greater than [R]/Rtot is observed for the third peak.
Indeed, the receptor module exhibits interesting input re-
sponse complexity.
Long-term dose response
We wanted to ﬁnd if a single dose could result in more than
one peak. It turns out that this is dose dependent because to
get a second peak, both the receptor and ligand must be
present. And to get the receptor recycled, the ligand must be
separated (reaction 8). This separated internalized ligand is
ubiquitinated and proteolyzed. Thus, in each cycle of the
receptor recovery, an equal amount of ligand is degraded.
Also, due to the afﬁnity of the ligand for the receptor, only
a small fraction of the ligand or the receptor (whichever
is limiting) remains unbound. This suggests that to observe a
second peak, the dose would have to be larger than Rtot. This
is validated by simulation results.
Only one peak is obtained for C5a dose # Rtot ¼ 40 nM,
but two peaks (or one peak and one plateau) are obtained for
C5a . 40 nM. Fig. 5 A shows the temporal response of
[Ca21]i (normalized) for increasing dose of C5a applied at
tLA ¼ 0. In Fig. 5 A, the temporal responses for the doses
resulting in a second peak or plateau are labeled. The y axis
has been truncated at 20% to better display the second peak
or plateau. At low doses up to C5a # 40 nM, only a single
peak is observed because by the time enough receptor is
recycled, all the ligand is degraded. A clear second peak is
obtained for C5a ¼ 50 nM. As C5a is further increased
beyond 60 nM, the height of the second peak remains the
same, but its shape becomes more like a plateau. For C5a ¼
200 nM, the plateau remains for hours. Fig. 5 B shows the
fraction of surface receptors with increasing dose. For C5a#
40 nM, the minimum fraction does not drop below 5%,
whereas for higher doses it drops to near zero as shown in the
inset. The minimum fraction drops to ;0.5% up to 50 s for
50 nM C5a and to 0.02%–0.05% up to 1000 s for 200 nM
C5a. With increasing doses, [R]/Rtot remains close to zero for
a longer time. In fact, the qualitative shapes of D[Ca21]i and
[R]/Rtot are inversely correlated. As [R]/Rtot starts to increase
substantially D[Ca21]i begins to drop. This is because as
long as some ligand is present, it has a tendency to bind to the
receptor and hence keep [R]/Rtot very low. Most of it is either
in the internalized form or is bound to the ligand and hence a
ﬁnite [Ca21]i is observed. Once all the ligand is degraded,
FIGURE 5 Long-term dose response. Increasing dose of C5a is applied at
tLA¼ 0 s and the system is simulated for 5000 s. The temporal responses for
the doses resulting in a second peak or plateau are labeled. (A) Temporal
response of [Ca21]i expressed as deviation from basal level as percentage of
maximum peak height for the ﬁrst peak across all doses. The y axis has been
clipped at 20% to better see the second peak. No second peak is observed for
C5a# 40 nM. A clear second peak is obtained for C5a ¼ 50 nM. As C5a is
further increased, the height of the second peak remains unchanged, but it
becomes a plateau. (B) Fraction of surface receptors with increasing dose.
For C5a # 40 nM, the minimum fraction does not drop below 5%, whereas
for higher doses it drops to near zero, as shown in the inset (;0.5% up to
50 s for 50 nM and 0.02%–0.05% up to 1000 s for 200 nM).
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more and more receptors remain free after recycling. Hence,
[R]/Rtot starts to increase and [L.R] drops quickly, resulting
in decreasing [Ca21]i. In short, the occurrence of the second
peak at C5a. 40 nM is directly correlated with Rtot;40 nM
with implications for inferring the total pool of surface
receptors.
It is interesting that a third peak cannot be obtained even
for very high doses. This is because to observe a third peak,
[C5a] must drop to zero and once this happens [C5a] cannot
increase again since it is only the receptor that is recovered
through recycling after internalization and not the ligand.
Beyond 60 nM C5a, it is not the height but the duration of
the second peak that increases. It is also interesting to note
that with increasing doses beyond 60 nM C5a, it is not the
height of the second peak that increases. Instead, the re-
sponse stays at this level for a longer time. The underlying
reason is that during this time frame, since ligand is present
in excess amounts and the receptor is the limiting species, for
all practical purposes, a lower-order system is established in
which a pseudo-steady state is attained and the ligand is
degraded at a nearly constant rate and that [L.R] remains
constant. In terms of the dynamics in the downstream mod-
ules, a pseudo-steady state is established since the channel
ﬂux is maintained over the plateau. Such responses can be
utilized for optimal design of drug dosage and release rate for
maximum efﬁcacy in pharmacodynamic studies. For exam-
ple, the data in Fig. 5 A suggest that the overall large dose
(e.g., .100 nM) can be administered in a ramp-wise fashion
up to 200 s to achieve almost uniform response without
exceeding a predeﬁned ﬁrst peak response.
Quantitative characterization of receptor
desensitization: dose response with a second
dose applied at a ﬁxed time
In the results discussed above, in one case two doses of 30
nM C5a were applied at different times and in the other case,
long-term response for a single dose with increasing strength
was predicted. The latter can be used to construct both the
receptor activation and receptor desensitization curves by
recording the peak of [L.R] and the minimum point of [R]
after applying the ligand. However, these are rarely mea-
sured directly. Hence, peak D[Ca21]i measurements are used
to construct the activation and desensitization curves (1). The
activation curve is essentially a normalized dose response
curve. The desensitization curve is constructed by applying a
second dose at a ﬁxed time later either of strength equivalent
to EC50 levels (1,27) or of the same strength as the ﬁrst dose.
We have carried out both. The time of applying the second
dose (tLA,2) is chosen so that the source chemicals, such as
PIP2 and [Ca
21]ER, in the downstream part have returned to
their basal levels. Also, the receptor should not have been
recycled signiﬁcantly. In our case, we have chosen tLA,2 ¼
250 s (tLA,1 ¼ 0 s). The essential idea behind applying the
second dose of the same strength is that we want to see the
response if the same external conditions are created repeat-
edly. The dose levels are C5a ¼ [1, 2, 5, 10, 20, 30, 40, 50,
60, 75, 100, 200, 400, 800] nM.
Second dose of equal strength
Fig. 6 A shows the dynamic response for three different
ligand strengths, viz. 10, 20, and 40 nM C5a. The maximum
response used for normalization is the same as the height of
the ﬁrst peak for C5a ¼ 800 nM. For clarity, the dynamic
responses for other doses are not shown in Fig. 6 A. For each
curve, the ratio of the second peak height (D[Ca21]i) to the
ﬁrst peak height is computed. This ratio is a measure of de-
sensitization.
Second dose of EC50 strength
Fig. 6 B shows the temporal responses for the three cases
when the second dose is of Rtot/2 strength, which is closely
related to the EC50 value for the ligand. However, this time,
FIGURE 6 The desensitization of the receptor at varying doses. Two doses are applied at tLA,1¼ 0 s and tLA,2¼ 250 s, respectively. (A) Temporal responses,
normalized with respect to the largest ﬁrst peak, are shown for the ﬁrst dose ¼ 10, 20, and 40 nM. The second dose is the same as the ﬁrst dose. From each
curve, the ratio of the height of the second peak to that of the ﬁrst peak is computed for use in C. (B) Normalized temporal responses with the second dose of
half-maximal EC50 strength (1,27) are shown. Here, the height of the second peak expressed as a fraction of the maximum height of the second peak is used for
C. (C) The desensitization curves computed using data from (A) ()), (B) (h), and the minimum value of [R]/Rtot between 0, t, 250 s (dash dot with circle
marks). The results from both (A) and (B) are quite similar even quantitatively. Half-maximal inhibitory concentration (IC50) value for the curve from data in
(B) is ;31 nM. At very high doses, (A) and (B) saturate to nonzero values since even a tiny amount of the receptor (due to recycling) is able to result in a
proportionally larger response due to sufﬁcient ligand strength.
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instead of computing the ratio of the two peaks for each curve,
the height of the second peak is normalized by the maximum
of the second peak height. These data also characterize the
desensitization (1,27).
Desensitization curves using calcium response
The two sets of data on desensitization are plotted in Fig. 6 C
(data from Fig. 6 A,); data from Fig. 6 B, h). For both the
curves, at low doses the ratio is close to 100%, starts to
decrease as the dose strength increases, and saturates to a
very low value. The saturated response is not exactly zero
since at high ligand strength as soon as a tiny amount of
receptor is recycled the unused ligand binds to it to elicit
some response. At very high doses, the saturation level of the
data from Fig. 6 A is about half compared to the data from
Fig. 6 B. This is because, in Fig. 6 B, the maximum peak
height of the second peak is the same as the height of the ﬁrst
peak at EC50 strength, which is clearly half of the maximum
height of the ﬁrst peak in Fig. 6 A. Apart from this, both
desensitization curves are very close. It is no surprise that
Garrad et al. (27) used the second dose of EC50 strength in
their experiments. The half-maximal inhibitory concentra-
tion (IC50) value for the curve from data in Fig. 6 B is ;31
nM, which is higher from the EC50 value of 18 nM for the
dose response curve (Fig. 6 F in the companion article). The
qualitative shape of the desensitization curve matches the pre-
dictions of Lemon et al. (1) and experimental observations of
Garrad et al. (27).
Desensitization curve using the receptor response
For completeness, in Fig. 6 C, we have also plotted [R]min/
Rtot (computed between 0 , t , 250 s) versus dose strength
from the simulation data for Fig. 6 A. This plot lies below
the other two desensitization curves because the fractional
value of [R]min/Rtot is always smaller than the corresponding
[Ca21]i response. This is partly due to CICR and partly due
to the more than additive effect of the tiny amounts of the
receptor. To understand the difference at lower doses,
consider C5a ¼ 10 nM as the ﬁrst dose in Fig. 6 B. At the
time the second dose is applied, [R] ;30 nM. The second
dose is C5a ¼ 20 nM. With [R] ¼ Rtot ¼ 40 nM, this had
resulted in 50% of maximum of ﬁrst peak height which is
;100% of the maximum of the second peak height. With 30
nM [R], the response will be somewhat lower. Fig. 6 C
shows this to be ;90%. Similarly, with 20 nM C5a as the
ﬁrst dose, ;75% (normalized) response is achieved for the
second peak, which is the right value for the 20 nM [R] and
20 nM C5a combination. Thus, quantitatively, all three
desensitization curves support each other.
Possible approach to quantitative validation
Unlike the KD studies, for the above long-term response, all
the experiments of Ca21 measurement could be conducted
on the same cell line within a time frame of 24 h. The time for
full recovery of the receptor at a dose up to 100 nM is ;2 h.
The dose used for the data shown in Fig. 4 is 30 nM. The
maximum dose required for obtaining the data used in Figs. 5
and 6 is 200 nM. So, a gap of ;2.5 h between applying the
dose corresponding to a new experiment (a particular curve
in Fig. 4 C, Fig. 5, A and B, or Fig. 6, A and B) is adequate.
Hence, 24 h are enough to generate data for validating the
results shown in Figs. 4–6, one at a time or;72 h to generate
data for all three ﬁgures. It is assumed that the same cell line
is used from which the data set 1 used for parameter con-
straining was generated because all predictions are based on
the corresponding parameters. In fact, this is an interesting
idea since, a fraction of the resulting experimental data can
actually be used for parameter constraining.
Sensitivity analysis of long-term response
Long-term response is affected by both the parameters that
affect the short-term response and the parameters related to
the reactions involved in the receptor internalization (kf,6,
[Arr], and kf,7), ligand separation (kf,8), and the recycling of
the receptor (kf,9). Since all these reactions in the recycle path
are in series and are of ﬁrst order, the associated time con-
stants could be potentially added and, hence, perturbation
of any of these parameters has a similar effect. Fig. 7 shows
the temporal response as a surface for perturbation in the
parameter kf,9 when two doses of 30 nM C5a are applied at 0
s (tLA,1) and at 500 s (tLA,2). The z axis is the deviation from
the basal level expressed as a percentage of the height of the
ﬁrst peak. The short-term response and, hence, the height of
FIGURE 7 Long-term response with a second dose under perturbation in
the parameter kf,9. The x axis is the time, and the y axis is the log2 of the per-
turbation factor. First dose of 30 nM C5a is applied at 0 s. The second dose
of 30 nM C5a is applied at 500 s. With increasing value of kf,9, the height of
the ﬁrst peak remains unchanged but that of the second peak increases.
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the ﬁrst peak does not change due to perturbation in kf,9.
However, with increasing kf,9, the receptor gets recycled
faster, i.e., more surface receptors are available by the time
t ¼ tLA,2 ¼ 500 s and, hence, the height of the second peak
increases. Other parameters such as kf,6, kf,7, [Arr], and kf,8
show a similar effect (not shown).
DISCUSSION
Using the model developed in part 1, the response of the
system has been predicted for the KD of several proteins in
the calcium network. Qualitative comparison with in vivo
data on the KD response has helped validate our model. To
correctly model the KDs resulting in changes in the basal
levels, e.g., KD of Ga,i, interaction with the ECM is critical.
The recent evidence about IP3R channels on the PM further
provides strength to this effect (28). Our model included the
mechanisms of receptor desensitization, internalization, and
recycling, which are critical for accurate prediction of long-
term response as revealed by single-parameter perturbation
analysis of long-term response.
Knockdown response
KD response plays the same role in quantitative modeling
of a biochemical system as knockout in network structure
(qualitative) modeling (29). KD response can serve to char-
acterize the efﬁcacy of the RNA interference (RNAi)-based
drugs (30). The KD response of most key players in the
network shown in Fig. 1 has been carried out and has been
qualitatively validated against the AfCS data. The KD re-
sponse has revealed the multiplicity of features in calcium
response (Table 1).
C5aR
C5a has been implicated in many disorders such as systemic
inﬂammatory response syndrome during infection by Sep-
ticemia (31), which can result in septic shock. Our results
show reduced G-protein activity and [Ca21]i response upon
KD of C5aR (Fig. 2 A). These effects reduce the expression
of inﬂammatory cytokines and the release of histamine.
Gb2
The KD of Gbg results in a sharp reduction in calcium levels
at low KDs (Fig. 2 B). Gbg has been termed one of the hot
spots of signaling (32). It interacts with many pathways and
proteins. Different binding sites on Gbg, e.g., for Ga, phos-
pholipases, and GRK, may be selectively targeted by small
molecules for therapeutic applications (33).
Gai2,3
KD of Gai results in increased peak height and basal level of
[Ca21]i response (Fig. 2 C). Decreased Ga,i levels have been
reported in Alzheimer’s disease (9). Interestingly, lowered
[Ca21]ER has also been reported in Alzheimer’s disease (15),
and our KD modeling study has shown that KD of Ga,i re-
sults in decreased basal [Ca21]ER.
RGS10
KD of RGS10 results in increased peak height of [Ca21]i
response linearly (Fig. 2 D). The AfCS has carried out KDs
on RGS2, RGS3, RGS10, and RGS16 in RAW 264.7 cells
(14). Similar to the results of KD of RGS10, KD of RGS2
in hypertensive patients increases calcium mobilization in-
duced by angiotensin II (34).
Knockdown of GRK2
KD of GRK results in increased and prolonged mobilization
of calcium (Fig. 2 E) since the receptor remains active for a
longer time. Thus, GRK regulates G-protein activity strongly.
In a recent study, increased expression of GRK2 in human
heart failure resulted in reducedb-adrenergic receptor-mediated
G-protein signaling (35).
Knockdown of PLCb-3
Similar to Gbg, KD of PLCb results in a sharp decrease in
[Ca21]i (Fig. 2 F). RAW 264.7 cells express three isoforms,
PLCb-2–4 (14). Consistent with the supralinear gain, it is sug-
gested that IP3 production may be more efﬁciently regulated
by altering the amount of PLCb-1–4 than by altering the
level of G-proteins (Ga,q/11) (36).
Among all the KDs discussed above, except for the
GPCR, all other proteins are inside the cell. Hence, their KD
effect can be achieved only through RNAi, in most cases.
However, since the receptor is at the plasma membrane, its
KD effect can be achieved by its pharmacological inhibition.
Receptor desensitization, internalization,
and recycling
We have extensively analyzed the receptor recovery part of
the system. We have shown that although receptor recycling
is not important for the quantitative modeling of the short-
term response, its accurate modeling is critical for predicting
the long-term response. An interesting application of char-
acterizing the receptor recycle system could be in formu-
lating optimal doses of agonists and antagonists to avoid
excessive desensitization of the receptor (37). Another po-
tential application is in understanding drug addiction and
tolerance or loss of sensitivity (38). We have demonstrated
that if a second dose is applied soon after the ﬁrst dose, to
achieve a certain level of subsaturated response, a higher
dose is needed. In the simplest form, this is the basis of
tolerance. Long-term dose response shows that when the
dose becomes higher than the total pool of receptors, the
response becomes bimodal instead of having just one peak.
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The duration of the second peak but not the peak height
increases as the dose strength is increased, becoming ﬂat and
thus taking the system into a pseudo-steady state at extremely
high doses.
Comparison with previous models and
experimental results
Receptor desensitization
As stated in the Results (Fig. 6, B and C), our receptor de-
sensitization results are in agreement qualitatively with those
for uridine triphosphate (UTP) with P2Y2 receptors presented
by Lemon et al. (1) and Garrad et al. (27). An excellent
semiquantitative agreement is also observed. For example,
the ratio of the half-maximal inhibitory concentration (IC50)
value for the desensitization curve in Fig. 6 B (;31 nM) to
the EC50 value for dose response curve (18 nM) 1.72 is in ex-
cellent agreement with those obtained by Lemon et al. (1) for
UTP with P2Y2 receptors: EC50 for dose response¼ 250 nM,
IC50 for desensitization curve¼ 430 nM, ratio¼ 1.72 (Fig. 7
A of Lemon et al. (1)).
Dose response of receptor internalization
Quantitative characterization of GPCR internalization is
necessary for therapeutic applications of GPCR agonists
(39). Fig. 4 shows the temporal response of calcium and
surface receptors for different doses. The data from the same
set of simulations are used to construct the dose response for
receptor internalization. Fig. 8 shows the dose response
curve for the internalized ligand-bound receptors (L.Ri). The
dose response of L.Ri is consistent with the experimental
observations of Conway et al. (40) for the ligand parathyroid
hormone in HEK-293 cells. The EC50 value is 21 nM, which
is slightly above the EC50 value of 18 nM for calcium
response. A similar result is experimentally obtained by
Conway et al., where the EC50 for internalization (35 nM,
Fig. 6 A of Conway et al.) is somewhat higher than the EC50
value for cAMP production (Fig. 1 of Conway et al.). These
results also qualitatively match with those for b(2)-adrener-
gic receptor in HEK-293 cells and CHO-K1 cells (Haasen
et al. (41)).
Experimental construction of receptor desensitization or
internalization requires experiments at several doses. Al-
though experiments have to be carried out for novel (pre-
viously uncharacterized) GPCRs and their agonists, the total
time and cost of experiments can be reduced through compu-
tational predictions made by a model that is based on experi-
mental data for the chosen agonist-receptor system at several
but at 2–3 times fewer doses. This philosophy of context-
speciﬁc modeling holds promise for high throughput screen-
ing of GPCRs (39).
Limitations
Even though the model proposed included details of the
GTPase cycle of G-protein Gi, other G-protein systems were
not included due to the linear increase in the number of
parameters to be estimated with the inclusion of additional
experimental data. Though the qualitative response is not
expected to change drastically if one were to include other
GTPase cycles and the details of the PLCb activation, quan-
titative differences are inevitable. Also, the level of detail is
tailored toward predicting calcium response, and not the
internal dynamics of individual modules. Hence, the lumped
models of the modules may not be used for such purposes.
Due to the existence of multiple parameter values with good
ﬁt to data, more emphasis should be on the qualitative
interpretation of the results and the predictions. The same
conclusion is arrived at due to the subcellular variability in the
response. Similarly, some of the downstream processes, such
as activation of Ca21/CaM-dependent kinases and other
components which could feed back into the upstream parts of
the network, are not included.
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